D
David Dripps
Researcher at Amgen
Publications - 12
Citations - 2286
David Dripps is an academic researcher from Amgen. The author has contributed to research in topics: Receptor antagonist & Interleukin 1 receptor antagonist. The author has an hindex of 9, co-authored 12 publications receiving 2239 citations.
Papers
More filters
Journal ArticleDOI
Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor
Hannum Charles H,Carol J. Wilcox,William P. Arend,Joslin Fenneke G,David Dripps,Patricia L. Heimdal,Lyman G Armes,Andreas Sommer,Stephen P. Eisenberg,Robert C. Thompson +9 more
TL;DR: Three interleukin-1 inhibitors have been purified to homogeneity from medium conditioned by human monocytes and partial sequence analysis and digestion with N-glycanase indicate that these are glycosylation forms of a single protein.
Journal ArticleDOI
Interleukin-1 (IL-1) receptor antagonist binds to the 80-kDa IL-1 receptor but does not initiate IL-1 signal transduction.
TL;DR: The failure to induce general, early responses characteristic of IL-1 indicates thatIL-1ra is unlikely to act as an agonist on any cell expressing the 80-kDa receptor.
Journal ArticleDOI
Vagal paraganglia bind biotinylated interleukin-1 receptor antagonist: a possible mechanism for immune-to-brain communication.
Lisa E. Goehler,Lisa E. Goehler,Jane Relton,David Dripps,Rachel Kiechle,Nichole Tartaglia,Steven F. Maier,Linda R. Watkins +7 more
TL;DR: Data suggest that centrally mediated illness responses result from IL1 activation of vagal paraganglia, a key mediator of immune-to-brain communication.
Journal ArticleDOI
Interleukin-1 receptor antagonist binds to the type II interleukin-1 receptor on B cells and neutrophils.
TL;DR: There may be a population of cells for which the actions ofIL-1 cannot be effectively opposed by IL-1ra, although this group does not include mature B cells and PMNs.
Journal ArticleDOI
X-ray crystal structure of a small antagonist peptide bound to interleukin-1 receptor type 1.
TL;DR: The structure of the extracellular domains ofIL-1R1 bound to a 21-amino acid IL-1 antagonist peptide shows an unexpected binding mode for the peptide and may contribute to the design of smaller IL- 1R antagonists.